AVBP compared with LEGN: revenue, margins and what each company keeps, and the suppliers and customers both name

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

LEGNLegend Biotech Corp

Mkt capRevenueRevenue

Compare

AVBPArriVent BioPharma, Inc.

LEGNLegend Biotech Corp

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

AVBP

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.3%▼−4.64%×0.28

May 12 '26±11.3%▼−0.17%×0.02

Q1 FY26±25.8%▼−7.21%×0.28

Nov 10 '25±21.0%▲+3.08%×0.15

LEGN

No earnings history for LEGN.

= impliedAVBP realized, solidLEGN realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

AVBPArriVent BioPharma, Inc.

13.63▲+11.42%· post 13.63

Mkt cap$649.4M

LEGNLegend Biotech Corp

23.41▲+3.86%· post 23.49

ClosedNov 6 '26

Mkt cap$4.3B

Compare

ClosedNov 6 '26

AVBPArriVent BioPharma, Inc.

LEGNLegend Biotech Corp

13.63▲+11.42%post 13.63

Price

23.41▲+3.86%post 23.49

$649.4M

Mkt cap

$4.3B

AVBP13.63▲+11.42%vsLEGN23.41▲+3.86%ClosedNov 6 '26